← Open Payments lookup

KAREN WHITEHEAD: Open Payments

NPI 1295037299 · WASHINGTON, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$471 in 18 payments from 10 companies in 2025. Trend: 2023 $1,074 · 2024 $349 · 2025 $471

Food & beverage: $451Long term medical supply or device loan: $20
CompanyPaymentsAmount
Amgen Inc.3$167
Otsuka America Pharmaceutical, Inc.3$73
Teva Pharmaceuticals USA, Inc.3$48
Abbott Laboratories2$44
Dexcom, Inc.2$37
ABBVIE INC.1$29
Indivior Inc.1$23
Neurocrine BioSciences, Inc.1$19
PFIZER INC.1$17
Novo Nordisk Inc1$15

Products named: REPATHA, REXULTI, Dexcom G6 Transmitter, UZEDY, VRAYLAR, OTEZLA, FREESTYLE LIBRE 2, SUBLOCADE.

Industry payments across NC — which companies pay providers there.